Role of hydrolytic degradation of polylactide drug carriers in developing micro- and nanoscale polylactide-based drug dosage forms
Crossref DOI link: https://doi.org/10.1007/s11172-020-2918-0
Published Online: 2020-09-18
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ermolenko, Yu. V.
Semyonkin, A. S.
Ulianova, Yu. V.
Kovshova, T. S.
Maksimenko, O. O.
Gelperina, S. E.
Text and Data Mining valid from 2020-08-01
Version of Record valid from 2020-08-01
Article History
Received: 30 September 2019
Revised: 27 November 2019
Accepted: 17 March 2020
First Online: 18 September 2020